ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 176 filers reported holding ARGENX SE in Q2 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $167,154,200 | +114.4% | 340,000 | +70.0% | 2.56% | +127.0% |
Q2 2023 | $77,946,000 | -6.6% | 200,000 | -10.7% | 1.13% | -6.2% |
Q1 2023 | $83,457,920 | +29.6% | 224,000 | +31.8% | 1.20% | +7.0% |
Q4 2022 | $64,401,100 | +52.0% | 170,000 | +41.7% | 1.12% | +52.8% |
Q3 2022 | $42,366,000 | -40.5% | 120,000 | -36.2% | 0.74% | -40.9% |
Q2 2022 | $71,229,000 | +13.0% | 188,000 | -6.0% | 1.24% | +2.0% |
Q1 2022 | $63,062,000 | -4.2% | 200,000 | +6.4% | 1.22% | +13.2% |
Q4 2021 | $65,836,000 | +4.8% | 188,000 | -9.6% | 1.08% | +1.2% |
Q3 2021 | $62,816,000 | +17.2% | 208,000 | +16.9% | 1.06% | +10.9% |
Q2 2021 | $53,591,000 | +29.7% | 178,000 | +18.7% | 0.96% | +1.2% |
Q1 2021 | $41,309,000 | +75.6% | 150,000 | +87.5% | 0.95% | +18.5% |
Q4 2020 | $23,527,000 | +5.4% | 80,000 | -5.9% | 0.80% | -1.1% |
Q3 2020 | $22,314,000 | +45.7% | 85,000 | +25.0% | 0.81% | +20.4% |
Q2 2020 | $15,316,000 | – | 68,000 | – | 0.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 49,950 | $14,690,000 | 5.25% |
Avoro Capital Advisors LLC | 902,500 | $265,416,000 | 4.57% |
Eagle Health Investments LP | 19,587 | $5,760,000 | 3.68% |
Redmile Group, LLC | 918,307 | $270,065,000 | 3.27% |
Bellevue Group AG | 945,348 | $278,018,000 | 3.18% |
AWM Investment Company, Inc. | 80,000 | $23,527,000 | 2.99% |
DCF Advisers, LLC | 24,000 | $7,058,000 | 2.91% |
Ikarian Capital, LLC | 201,500 | $59,260,000 | 2.61% |
JGP Global Gestao de Recursos Ltda. | 1,859 | $547,000 | 2.06% |
Evolutionary Tree Capital Management, LLC | 8,798 | $2,587,000 | 1.97% |